Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems
Jenna Buckwalter, Wilson Chan, Lauren Shuman, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2599-2599
Open Access | Times Cited: 21

Showing 21 citing articles:

Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro
Hui Xie, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4682-4682
Open Access | Times Cited: 17
New Approaches to Targeting Epigenetic Regulation in Bladder Cancer
Daryl Thompson, Nathan Lawrentschuk, Damien Bolton
Cancers (2023) Vol. 15, Iss. 6, pp. 1856-1856
Open Access | Times Cited: 9
Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma
Michèle J. Hoffmann, Wolfgang A. Schulz
Cancers (2021) Vol. 13, Iss. 23, pp. 6040-6040
Open Access | Times Cited: 22
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
Dimitrios Goutas, Stamatios Theocharis, Gerasimos Tsourouflis
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1346-1346
Open Access | Times Cited: 19
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
Michèle J. Hoffmann, Sarah Meneceur, Katrin Hommel, et al.
Genes (2021) Vol. 12, Iss. 2, pp. 260-260
Open Access | Times Cited: 18
Sodium Valproate, a Histone Deacetylase Inhibitor, Provokes Reactive Oxygen Species–Mediated Cytotoxicity in Human Hepatocellular Carcinoma Cells
Prabakaran Rithanya, Devaraj Ezhilarasan
Journal of Gastrointestinal Cancer (2020) Vol. 52, Iss. 1, pp. 138-144
Closed Access | Times Cited: 12
Epigenetics of Urological Cancers
Wolfgang A. Schulz, Karina D. Sørensen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4775-4775
Open Access | Times Cited: 9
Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network
Yan Gu, Xiaozeng Lin, Anil Kapoor, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 430-430
Open Access | Times Cited: 8
The association of clinicopathological characterizations of colorectal cancer with membrane-bound mucins genes and LncRNAs
Hossein Iranmanesh, Maliheh Entezari, Leili Rejali, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153883-153883
Closed Access | Times Cited: 5
Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
Xiaozeng Lin, Yan Gu, Yingying Su, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2805-2805
Open Access | Times Cited: 5
Epigenetic Priming and Development of New Combination Therapy Approaches
Sarah Meneceur, Camilla M. Grunewald, Günter Niegisch, et al.
Methods in molecular biology (2023), pp. 259-281
Closed Access | Times Cited: 2
Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis
Ilaha Isali, Phillip McClellan, Adam Calaway, et al.
Urologic Oncology Seminars and Original Investigations (2022) Vol. 40, Iss. 5, pp. 197.e11-197.e23
Open Access | Times Cited: 3
Structure-based identification of novel histone deacetylase 4 (HDAC4) inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
Sébastien Rinaldetti, Qiong Zhou, Joshua M. Abbott, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10605-10605
Open Access | Times Cited: 3
Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 867-867
Open Access
Transcriptome-based network analysis related to histone deacetylase genes and identified EMP1 as a potential biomarker for prognosis in bladder cancer
Bao Qiong, Yan Li, Yu Chen, et al.
Clinical Genitourinary Cancer (2024) Vol. 23, Iss. 1, pp. 102262-102262
Closed Access
DNA Methylation and Chromatin Regulators in Bladder Cancer
Wolfgang A. Schulz, Michèle J. Hoffmann
(2024), pp. 181-217
Closed Access
Strong Involvement of Classical Histone Deacetylases and Mechanistically Distinct Sirtuins in Bellicose Cancers
Shabir Ahmad Ganai
(2020), pp. 75-95
Closed Access | Times Cited: 3
Singlet Anticancer Therapy Through Epi-Weapons Histone Deacetylase Inhibitors and Its Shortcomings
Shabir Ahmad Ganai
(2020), pp. 173-201
Closed Access | Times Cited: 1
DNMT3A promotes the proliferation and metastasis of esophageal squamous cell carcinoma via upregulating HDAC9
Minghong Pan, Yingtong Feng, Peng Ding, et al.
Research Square (Research Square) (2022)
Open Access
The role of clinical metabolomics in the diagnosis of bladder cancer
S. A. Zamyatnin, A. V. Malushko, Irina S. Gonchar
Urology reports (St - Petersburg) (2022) Vol. 12, Iss. 3, pp. 229-238
Closed Access
Page 1

Scroll to top